PDS Biotechnology Corporation (PDSB) Stock Analysis & Investment Frameworks
PDS Biotechnology Corporation (PDSB) stock analysis on Invetso. Review PDS Biotechnology Corporation’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
PDS Biotechnology Corporation Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
PDS Biotechnology Corporation Key Financial Metrics
- Market Cap: $72.56M
- Revenue: $N/A
- ROE: -708.20%
- ROIC: -3550.39%
- Dividend Yield: N/A
About PDS Biotechnology Corporation
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing innovative, multi-functional immunotherapies to combat cancer. Its primary drug candidate, PDS0101 (HPV16), is currently undergoing Phase II clinical trials, positioned as an initial treatment option for recurrent or metastatic head and neck cancer, human papillomavirus (HPV)-associated malignancies, and cervical cancer. The company's developmental pipeline further includes several preclinical product candidates. These comprise PDS0102, utilizing T-cell receptor gamma alternate reading frame protein (TARP) for prostate and breast cancers; PDS0103 (MUC-1) targeting ovarian, colorectal, lung, and breast cancers; and PDS0104, which incorporates Tyrosinase-related protein 2 for the treatment of melanoma. Beyond oncology, PDS Biotechnology is also engaged in developing treatments for infectious diseases, with candidates such as PDS0201 for tuberculosis, PDS0202 as an investigational influenza vaccine, and PDS0203, a vaccine aimed at preventing COVID-19. The company has established strategic partnerships and licensing agreements with notable entities including the National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is headquartered in Florham Park, New Jersey.
PDS Biotechnology Corporation Investment Frameworks
Invetso analyzes PDS Biotechnology Corporation (PDSB) across the following frameworks:
- PDS Biotechnology Corporation 10Y Growth Potential
- PDS Biotechnology Corporation Scenario Analysis
- PDS Biotechnology Corporation Risks & Opportunities
- PDS Biotechnology Corporation Economic Moat
- PDS Biotechnology Corporation Business Model
- PDS Biotechnology Corporation Management
- PDS Biotechnology Corporation SWOT Analysis
- PDS Biotechnology Corporation Porter's 5 Forces
- PDS Biotechnology Corporation PESTLE Analysis
- PDS Biotechnology Corporation ESG Analysis